This article will address the topic of Osaterone, a matter of great relevance and interest today. Osaterone has captured the attention of experts and the general public due to its impact on various areas of society. Along these lines, different aspects related to Osaterone will be examined, from its origin and evolution, to its implications in the contemporary world. The opinions and positions of specialists in the matter will also be analyzed, as well as the possible solutions or measures to be taken regarding this issue. Without a doubt, Osaterone is a topic that leaves no one indifferent, so it is essential to deepen its study and understanding to achieve a more complete and clarifying vision.
Clinical data | |
---|---|
Other names | TZP-5258; Gestoxarone; 2-Oxachloromadinone; 17α-Hydroxy-6-chloro-2-oxa-6-dehydroprogesterone; 17α-Hydroxy-6-chloro-2-oxapregna-4,6-diene-3,20-dione |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H25ClO4 |
Molar mass | 364.87 g·mol−1 |
3D model (JSmol) | |
| |
|
Osaterone (developmental code name TZP-5258), also known as 17α-hydroxy-6-chloro-2-oxa-6-dehydroprogesterone, as well as 2-oxachloromadinone, is a steroidal antiandrogen and progestin that was never marketed. The C17α acetate ester of osaterone, osaterone acetate, in contrast, has been marketed.
PRTooltip Progesterone receptor |
| ||||||
---|---|---|---|---|---|---|---|
mPRTooltip Membrane progesterone receptor (PAQRTooltip Progestin and adipoQ receptor) |
| ||||||
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |